Results 21 to 30 of about 46,125 (278)
Genetic Transformation of Candida glabrata by Electroporation [PDF]
BIO-PROTOCOL, 2015 Here, we report a method for the transformation by electroporation of the human fungal pathogen Candida glabrata (C. glabrata). The protocol can be used for transformations in single well or in 96-well microtiter plates. It has been extensively used to generate a genome-scale gene deletion library using the C.
Fabian Istel +3 more
openaire +4 more sources
Genetic Transformation of Candida glabrata by Heat Shock
Bio-Protocol, 2015 Here, we report a method for the transformation of Candida glabrata using a heat shock method. The protocol can be used for transformations in single well or in 96-well scale.
Fabian Istel +3 more
doaj +1 more source
Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris [PDF]
, 2017 The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive
Borman, Andrew +6 more
core +4 more sources
mSphere, 2023 The World Health Organization recently published the first list of priority fungal pathogens highlighting multiple Candida species, including Candida glabrata, Candida albicans, and Candida auris.
Justin B. Gregor +8 more
doaj +1 more source
Bloodstream yeast infections: a 15-month survey [PDF]
, 2009 A 15-month survey of 412 bloodstream yeast isolates from 54 Belgian hospitals was undertaken. Candida albicans was the most common species (47.3%) followed by C. glabrata (25.7%), C. parapsilosis (8.0%), C. tropicalis (6.8%) and Saccharomyces cerevisiae (
Detandt, M +3 more
core +1 more source
Emergence of resistantCandida glabratain Germany [PDF]
JAC-Antimicrobial Resistance, 2021 AbstractBackgroundCandida glabrata is the second leading fungal pathogen causing candidaemia and invasive candidiasis in Europe. This yeast is recognized for its rapid ability to acquire antifungal drug resistance.ObjectivesWe systematically evaluated 176 C.
Ronny Martin +5 more
openaire +3 more sources
Case Reports in Women's Health, 2022 A case is reported of Candida glabrata microbial invasion of the amniotic cavity and maternal candidemia with a negative 1,3-β-D-glucan test. A 28-year-old singleton pregnant woman (gravida 1, para 0) presented at 18 weeks and 3 days of gestation ...
Michihisa Shiro +3 more
doaj +1 more source
Surface disinfection challenges for Candida auris: an in-vitro study [PDF]
, 2018 The emerging pathogenic multidrug-resistant yeast Candida auris is an important source of healthcare-associated infections and of growing global clinical concern.
Akinbobola, A. +9 more
core +4 more sources
Vaginal yeasts in the era of "over the counter" antifungals [PDF]
, 2000 OBJECTIVE: To establish whether there has been any rise in the prevalence of non-albicans Candida species isolated from vaginal swabs since the introduction of “over the counter” antifungal treatments.
Ashbee, H.R. +4 more
core +8 more sources
Candida glabrata meningitis and endocarditis: a late severe complication of candidemia
International Journal of Infectious Diseases, 2014 We report an unusual case of Candida glabrata meningitis and endocarditis in a young Caucasian woman with a prosthetic aortic valve and suffering from a dissecting thoraco-abdominal aortic aneurysm. C.
Claudia Colomba +5 more
doaj +1 more source